AURO-OLANZAPINE ODT 20 olanzapine 20 mg orally disintegrating tablet blister pack
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Patient Information leaflet
(PIL)
24-08-2020
Public Assessment Report
(PAR)
26-11-2017
Send request.
Active ingredient:
olanzapine, Quantity: 20 mg
Available from:
Arrotex Pharmaceuticals Pty Ltd
INN (International Name):
Olanzapine
Pharmaceutical form:
Tablet, orally disintegrating
Composition:
Excipient Ingredients: polacrilin potassium; colloidal anhydrous silica; mannitol; sodium stearylfumarate; crospovidone; aspartame; microcrystalline cellulose; Flavour
Administration route:
Oral
Units in package:
28, 7
Prescription type:
(S4) Prescription Only Medicine
Therapeutic indications:
For the treatment of schizophrenia and related psychoses. Alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.
Product summary:
Visual Identification: Yellow coloured, circular, flat faced beveled edge tablets debossed with 'C' on one side and '54' on the other side; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Authorization status:
Registered
Authorization date:
2014-08-26
Patient Information leaflet
AURO-OLANZAPINE ODT
CONSUMER MEDICINE INFORMATION
Ver 1.1
Page 1 of 5
AURO-OLANZAPINE ODT 5, 10, 15 & 20
Olanzapine
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet is designed to provide
you with answers to some common
questions
about
this
medicine.
It
does
not
contain
all
the
available
information and does not take the
place of talking with your doctor.
The information in this leaflet was
last updated on the date shown on
the
final
page.
More
recent
information about this medicine may
be available.
Make
sure
you
speak
to
your
pharmacist or doctor to obtain the
most up to date information on this
medicine. The updated leaflet may
contain important information about
AURO-OLANZAPINE ODT and its
use that you should be aware of.
All
medicines
have
risks
and
benefits.
Your doctor has more information
about this medicine than is contained
in this leaflet. Also, your doctor has
had the benefit of taking a full and
detailed history from you and is in
the best position to make an expert
judgement to meet your individual
needs.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, TALK TO YOUR
DOCTOR OR PHARMACIST.
KEEP
THIS
LEAFLET
WITH
THIS
MEDICINE.
You may need to read it again.
WHAT AURO-OLANZAPINE
ODT IS USED FOR
AURO-OLANZAPINE
ODT
belongs
to
a
group
of
medicines
called
antipsychotics.
It
helps
to
correct chemical imbalances in the
brain,
which
may
cause
mental
illness.
AURO-OLANZAPINE ODT is used
to treat symptoms of schizophrenia
and related psychoses. Schizophrenia
is a mental illness with disturbances
in thinking, feelings and behaviour.
AURO-OLANZAPINE ODT alone,
or in combination with lithium or
valproate, is used for the short-term
treatment
of
acute
manic
episodes
associated with Bipolar I Disorder.
AURO-OLANZAPINE ODT is also
a
mood
stabiliser
that
prevents
further occurrences of the disabling
high and low (depressed) extremes
of mood associated with Bipolar I
Disorder.
Bipolar I Disorder is a mental illness
with
symptoms
such
as
feeling
"high", having excessive amounts of
energy, needing
Read the complete document
